Litcius/Paper detail

Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy

Jie Zheng, Mingshuang Wang, Liwei Pang, Shuai Wang, Yanan Kong, Xueqin Zhu, Xiuman Zhou, Xiaoxi Wang, Chunxia Chen, Haoming Ning, Wenshan Zhao, Wenjie Zhai, Yuanming Qi, Yahong Wu, Yanfeng Gao

2024Journal of Controlled Release37 citationsDOI

Topics & Concepts

Cross-presentationAdjuvantDendritic cellImmune systemCancer immunotherapyAntigenImmunotherapyAntigen presentationCancer researchCpG OligodeoxynucleotideCancer vaccinePLGACD8T cellBiologyImmunologyBiochemistryGene expressionIn vitroDNA methylationGeneImmunotherapy and Immune ResponsesRNA Interference and Gene Deliveryvaccines and immunoinformatics approaches
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy | Litcius